螺[1,3-二氧戊环-2,9'(6'H)-[2,7](环氧十五碳环[1,11,13]三烯亚氨基)萘并[2,1-b]呋喃]-1',4,6',11'(2'H)-四酮, 5',17',19',21'-四羟基-23'-甲氧基-2',4',12',16',18',20',22'-七甲基-21'-乙酸酯 - CAS:14487-05-9

螺[1,3-二氧戊环-2,9'(6'H)-[2,7](环氧十五碳环[1,11,13]三烯亚氨基)萘并[2,1-b]呋喃]-1',4,6',11'(2'H)-四酮, 5',17',19',21'-四羟基-23'-甲氧基-2',4',12',16',18',20',22'-七甲基-21'-乙酸酯

英文名： Spiro[1,3-dioxolane-2,9'(6'H)-[2,7](epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan]-1',4,6',11'(2'H)-tetrone, 5',17',19',21'-tetrahydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-21'-acetate 别名：二恶酮利福霉素;利福霉素O;利福霉素-O;利福霉素;利福霉素 0;利福霉素0

商品编号：R100744-5g 规格：5g 纯度：97%

CAS号： 14487-05-9 分子式：C39H47NO14 分子量：753.79

价格	¥ 156.00 （请登录会员查看折扣价）
货期	5~7个工作日

数量

中文名称：	螺[1,3-二氧戊环-2,9'(6'H)-[2,7](环氧十五碳环[1,11,13]三烯亚氨基)萘并[2,1-b]呋喃]-1',4,6',11'(2'H)-四酮, 5',17',19',21'-四羟基-23'-甲氧基-2',4',12',16',18',20',22'-七甲基-21'-乙酸酯
中文别名：	二恶酮利福霉素;利福霉素O;利福霉素-O;利福霉素;利福霉素 0;利福霉素0
smiles：	COC1C=COC2(C(=O)C3=C(C(=C(O)C4=C3C3(C=C(C4=O)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)OCC(=O)O3)C)O2)C \|c:27,t:3,29\|
英文名称：	Spiro[1,3-dioxolane-2,9'(6'H)-[2,7](epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan]-1',4,6',11'(2'H)-tetrone, 5',17',19',21'-tetrahydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-21'-acetate
英文别名：	Rifamycin O;Rifamycin-O;4-o-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-rifamycigamma-la;ctone;Rifomycin O;Aceticacid, [(1,2,6,9-tetrahydro-5,9,17,19,21-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,6,11-trioxo-2,7-(epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-9-yl)oxy]-,g-lactone, 21-acetate (7CI);Rifomycin O (6CI);Spiro[1,3-dioxolane-2,9'(6'H)-[2,7](epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan]-1',4,6',11'(2'H)-tetrone,5',17',19',21'-tetrahydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-,21'-acetate (8CI);Spiro[1,3-dioxolane-2,9'(6'H)-[2,7](epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan],rifamycin deriv;NSC 182391;Rifaximin EP Impurity F;Rifaximin impurity F (EP);4’,12’,16’,18’,20’,22’-heptamethyl--221’-acetate;4-O-(CARBOXYMETHYL)-1-DEOXY-1,4-diHYDRO-4-HYDROXY-1-OXO-G-LACTONE;4-O-Carboxymethyl-1-deoxy-1,4-dihydro-4-hydroxy-1-oxorifamycin γ-lactone;Rifamycin;NSC182391;RIFAMYCIN-O;14487-05-9;Rifamycin, 4-O-(carboxymethyl)-1-deoxy-1,4-dihydro-4-hydroxy-1-oxo-, gamma-lactone;LMPK05000004;C01849;RAFHKEAPVIWLJC-KQOHHTLASA-N;DTXSID201023447;(2'S,12'Z,14'E,16'S,17'S,18'R,19'R,20'R,21'S,22'R,23'S,24'E)-5',17',19'-trihydroxy-23'-methoxy-2',4',12',16',18',20',22'-heptamethyl-1',4,6',11'-tetraoxo-1',2'-dihydro-6'H-spiro[1,3-dioxolane-2,9'-[2,7](epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan]-21'-yl acetate;(trihydroxy-methoxy-heptamethyl-4-tetraoxo-spiro[1,3-dioxolane-2,[?]-[?]]yl) acetate;Q27101853;CHEBI:16324;KS-1408;SCHEMBL18494827;AKOS024255722;RIFAMYCIN O;rifamycin O
CAS号：	14487-05-9
分子式：	C39H47NO14
分子量：	753.79
密度：
熔点：
沸点：
闪点：
水溶性：
蒸气压：

搜索质检报告(COA)

搜索MSDS